Display options
Share it on

Front Immunol. 2013 May 06;4:103. doi: 10.3389/fimmu.2013.00103. eCollection 2013.

Interaction of the Capsular Polysaccharide A from Bacteroides fragilis with DC-SIGN on Human Dendritic Cells is Necessary for Its Processing and Presentation to T Cells.

Frontiers in immunology

Karien Bloem, Juan J García-Vallejo, Ilona M Vuist, Brian A Cobb, Sandra J van Vliet, Yvette van Kooyk

Affiliations

  1. Department of Molecular Cell Biology and Immunology, VU University Medical Center Amsterdam, Netherlands ; Centre for Specialized Nutrition, Danone Research Wageningen, Netherlands.

PMID: 23653626 PMCID: PMC3644800 DOI: 10.3389/fimmu.2013.00103

Abstract

The zwitterionic capsular polysaccharide A (PSA) of Bacteroides fragilis is the first carbohydrate antigen described to be presented in major histocompatibility complex (MHC) class II for the induction of CD4(+) T cell responses. However, the identity of the receptor mediating binding and internalization of PSA in antigen presenting cells remains elusive. C-type lectins are glycan-binding receptors known for their capacity to target ligands for antigen presentation to T cells. Here, we investigated whether C-type lectins were involved in the internalization of PSA and identified dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) as the main receptor for PSA on human dendritic cells (DC). The induction of PSA-specific T cell proliferation appeared to be completely dependent on DC-SIGN. These data reveal a crucial role for DC-SIGN in the endocytosis and routing of PSA in human DC for the efficient stimulation of PSA-specific CD4(+) T cells.

Keywords: C-type lectin; T cell proliferation; dendritic cell; pathogen; polysaccharide

References

  1. Annu Rev Immunol. 2012;30:491-529 - PubMed
  2. Int J Cancer. 2008 Feb 15;122(4):839-46 - PubMed
  3. Cell. 2000 Mar 3;100(5):575-85 - PubMed
  4. Immunol Cell Biol. 2008 Oct;86(7):580-7 - PubMed
  5. J Biol Chem. 2000 Mar 10;275(10):6733-40 - PubMed
  6. J Exp Med. 2003 Jan 6;197(1):7-17 - PubMed
  7. J Immunol. 2003 Feb 15;170(4):1635-9 - PubMed
  8. Blood. 2002 Sep 1;100(5):1780-6 - PubMed
  9. Cell. 2000 Mar 3;100(5):587-97 - PubMed
  10. Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12204-9 - PubMed
  11. Nat Immunol. 2009 Oct;10(10):1081-8 - PubMed
  12. J Exp Med. 1994 Aug 1;180(2):745-9 - PubMed
  13. Glycobiology. 2011 Apr;21(4):512-20 - PubMed
  14. J Biol Chem. 2006 Jul 21;281(29):20440-9 - PubMed
  15. J Biol Chem. 2002 Mar 29;277(13):11314-20 - PubMed
  16. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5183-8 - PubMed
  17. Immunology. 2009 May;127(1):73-82 - PubMed
  18. J Leukoc Biol. 2003 May;73(5):621-9 - PubMed
  19. Cell. 2004 May 28;117(5):677-87 - PubMed
  20. Nat Rev Drug Discov. 2010 Apr;9(4):308-24 - PubMed
  21. Nat Med. 2010 Oct;16(10):1128-33 - PubMed
  22. Mol Immunol. 2013 Apr;53(4):387-97 - PubMed
  23. Int Immunol. 2004 Jun;16(6):819-29 - PubMed
  24. Biochemistry. 2002 Dec 24;41(51):15144-51 - PubMed
  25. Infect Immun. 2000 Dec;68(12):6650-5 - PubMed
  26. J Immunol. 2002 Dec 1;169(11):6149-53 - PubMed
  27. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8356-60 - PubMed
  28. Curr Opin Microbiol. 2002 Feb;5(1):92-6 - PubMed
  29. J Exp Med. 2011 May 9;208(5):1041-53 - PubMed
  30. J Immunol. 2002 Mar 1;168(5):2118-26 - PubMed
  31. J Exp Med. 2002 Dec 2;196(11):1435-46 - PubMed
  32. J Biol Chem. 1992 Sep 5;267(25):18230-5 - PubMed
  33. Glycobiology. 2008 Sep;18(9):707-18 - PubMed

Publication Types

Grant support